New weekly shot aims to tame type 1 diabetes alongside insulin pumps
NCT ID NCT06630585
Summary
This study is testing if adding a once-weekly medication called tirzepatide to automated insulin pump therapy helps adults with type 1 diabetes manage their blood sugar better. Researchers will compare the new combination to standard insulin pump therapy alone in 42 participants over 12 weeks. The main goal is to see if people spend more time in a healthy blood sugar range and can reduce their total daily insulin dose.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES (T1D) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
DiaCenTRE - Hirslanden Clinique des Grangettes
RECRUITINGChêne-Bougeries, Canton of Geneva, 1224, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Kantonsspital Olten
RECRUITINGOlten, Canton of Solothurn, 4600, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Luzerner Kantonspital
RECRUITINGLucerne, 6000, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.